AMLX – amylyx pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Amylyx Pharmaceuticals (AMLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $34.00 price target on the stock.
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals (AMLX) had its price target raised by Guggenheim from $25.00 to $30.00. They now have a "buy" rating on the stock.
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. [Yahoo! Finance]
Amylyx Pharmaceuticals (AMLX) was upgraded by Wall Street Zen from "s
Form 8-K Amylyx Pharmaceuticals, For: Mar 24
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Bedrosian Camille L
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Cohen Joshua B
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: FRATES JAMES M
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Mazzariello Gina
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.